Jump to content

Draft:Karen Rommelfanger

From Wikipedia, the free encyclopedia
  • Comment: Far too much self-promotion (bragging), Many things which are routine (WP:MILL) are written as if they are significant, for instance an "Electron Microscopy Fellowship". That might convince some, but not experienced academics.
    1. Cut the fluff
    2. If you can find notable awards, nothing listed is.
    3. Organize a Google scholar profile so we can see publication record.
    4. Look and analyze other pages as examples. Ldm1954 (talk) 22:09, 13 September 2024 (UTC)

Karen S. Rommelfanger is the founder of Institute of Neuroethics (the first neuroethics-focused international think and do tank), as well as the Ningen Neuroethics Co-Lab (the first neuroethics consultancy).[1] She provides consulting services on an international scale on the topic of neuroethics, connecting stakeholders across large-scale organizations to integrate ethical thought with innovation in neurotechnology. [1] She is also an Adjunct Associate Professor in both the Department of Neurology and the Department of Psychiatry & Behavioral Sciences at Emory University.[1]

Education [2]

[edit]

Rommelfanger studied at Angelo State University on a full academic ride from the Carr Scholarship. In 1999, she graduated Summa Cum Laude with a B.S. in chemistry. She participated in a P.E.T. Pharmacology Internship at the University of Michigan Nuclear Medicine Division in 1998. She earned her M.S. in Neurotoxicology in 2002 from the College of Pharmacy at the University of Texas, Austin. In 2002, she received additional training in immunochemistry at the University of Texas Southwestern Medical School.

Rommelfanger pursued her Ph.D. in Neuroscience at Emory University in the School of Medicine and Department of Human Genetics, completing it in 2007. Additionally, she trained in rodent surgery at the University of Otago in Dunedin, New Zealand. Between 2008 and 2013, she completed a series of fellowships, including:

  • The Electron Microscopy Fellowship at the Emory University School of Medicine, Department of Neurology (2008-2009)
  • The Neurobiology Fellowship at the Okinawa Institute of Science and Technology, Neurobiology Unit (2008-2009)
  • The Electrophysiology Fellowship at Emory University, Yerkes National Primate Research Center (2009-2011)
  • Postdoctoral Fellow at Emory University, Scholars Program for Interdisciplinary Neuroscience Research under the School of Medicine and Department of Neurology (2011 - 2013)

Career [2]

[edit]

Currently, Rommelfanger is a Senior Faculty Fellow at the Emory University Center for Ethics. She also serves as an affiliate faculty member for the Neuroscience Graduate Program in the Division of Biological and Biomedical Sciences, and for Neuroscience and Behavioral Biology at the College of Arts and Sciences. She is also on the affiliate faculty at the Georgia Tech Engineering Center, working on neuroethics. Outside of academia, she is the founder and director of the Institute of Neuroethics, a “think and do tank” that she started in 2021. She is also the founder and CEO of the Ningen Neuroethics Co-Lab, which she started in 2020.

Rommelfanger is known for starting the Neuroethics Program at Emory University, which she directed until 2021. She also directed the Jones Program in Ethics at the Laney Graduate School, as well as the Responsible Conduct of Research Training at the Emory University Medical School’s Office of Postdoctoral Education. She founded and directed the Functional Neurological Disorders Pilot Clinic from 2017-2018, which is still ongoing.

Rommelfanger has held multiple previous faculty positions including Associate Professor of Neurology in the Division of Movement Disorders at the Emory University School of Medicine, Assistant Professor of Neurology in the Division of Movement Disorders, and Senior Associate in the Department of Neurology.

Published Work

[edit]

Much of Rommelfanger’s work focuses on how neurotechnology impacts approaches to health and disease.[3][4][5][6] She has investigated the ethics of predicting brain health through preclinical detection of diseases, particularly the design and research involved in these technologies and their potential impact on personhood.[3] Her work also explores the ethics of online brain training programs and how they bring individuals unusually close to brain science. She seeks to bring “socio-technical” considerations to the engineering of neurotechnology to enhance their potential positive impact.[4] Rommelfanger, among others, authored a multidisciplinary conference review looking into stigma surrounding functional neurological disorders, creating a plan to enhance research, patient empowerment, and clinician training in this area.[5] She has advocated for placebo techniques as therapies for psychogenic movement disorders, seeking to trigger international conversations on the subject.[6]

Rommelfanger also works extensively on global and cultural considerations within neuroethics.[7][8][9][10][11] In a special issue of Neuron, she discussed neuroethics as an emerging global phenomenon and the potential for conflicting cultural values.[7] In 2020, she addressed the role of neuroethics during a time of global crisis, amidst COVID-19 and anti-racism protests, calling for greater cultural awareness in neuroscience research and a heightened emphasis on the importance of neuroethics.[8] She also co-authored a list of neuroethics questions for the consideration of international brain initiatives, with a focus on multiculturalism.[9] Her cultural considerations extend to research bias, particularly the white Western individualistic bias prevalent in studies conducted on college students.[10] She has also addressed issues of access, especially the ethical challenges that arise from portable MRIs intended for rural and underrepresented areas.[11]

Rommelfanger pays particular attention to neuroethics within the private sector.[12][13] Following the publication of neuroethical guidelines, she worked to interview 21 neuro-entrepreneurs to assess their challenges in innovation and explore how they could align with neuroethicists to promote socially impactful entrepreneurship.[12] She also co-wrote an article discussing how neuroethics in innovation can be socially impactful and beneficial to entrepreneurs beyond risk mitigation and compliance.[13]

Science policy and diplomacy constitute a significant portion of Rommelfanger’s work.[14][15][16][17][18] She collaborated on the “Neurotechnology Toolkit” for policymakers for the Organisation for Economic Co-operation and Development (OECD)[14] as well as on their rapporteur for the “Neurotechnologies and Human Rights Framework: Do We Need New Human Rights?” conference.[15] Additionally, she co-authored the “Neuroethics guidance documents” with other leading experts in the field.[16] She wrote about the implementation of neurorights for Science & Diplomacy[17] and appeared on NPR to discuss the major ethical questions in neuroscience.[18]

Awards[2]

[edit]

Karen Rommelfanger has been the recipient of many awards throughout her career, including:

  • The Pre-doctoral Fellowship at the University of Texas at Austin (Center for Molecular & Cellular Toxicology, 2001)
  • Women in Neuroscience Travel Award, from the Society for Neuroscience (2005)
  • Fellow, Mind and Life Summer Research Institute (2006, 2007)
  • Early Scholar Award, from the Brain Matters International Neuroethics Conferences (2012)
  • Postdoctoral Scholarship, Scholars Program in Interdisciplinary Neuroscience Research at Emory University (2011 - 2013)
  • Top 25 Abstracts from International Neuroethics Society, American Journal of Bioethics Neuroscience (2012, 2013, 2014)
  • Phi Beta Kappa Honor Society Mentor Award (2020)

Societies & Affiliations

[edit]

Rommelfanger has been involved with various organizations throughout her career, holding leadership positions in many of them.[2] She currently offers consulting services for many organizations,[2] and was one of five national bioethicists selected to review and create a neuroethics brain map for the National Institutes of Health BRAIN Initiative Neuroethics Workgroup.[19] She is also the first neuroethics editorial advisory member of Neuron[20] and serves on the Neuroethics Advisory Board at BrainMind.[21]

Rommelfanger’s work extends globally as a Steering Committee Member for the Neuroscience-Inspired Policy Initiative at the Organization for Economic Cooperation and Development (OECD).[22] She also serves on the committee of the National Academies of Sciences, Engineering, and Medicine, working on the “Engaging Scientists in Shared Responsible Innovation in Neuroscience in Southeast Asia” workshop series.[2][23] In addition, she consults on security issues for the Defense Advanced Research Program Agency (DARPA.[2]

Previously, Rommelfanger founded NeuroEthics Women Leaders (NEW) and directed it until 2021.[2] For the International Neuroethics Society, she has served as a co-chair of multiple committees and as an Executive Board Member.[2] Her experience also includes educational initiatives, such as the Neuroethics Education Curriculum Committee at the International Brain Research Organization.[2]

In addition to advisory positions and conference participation, Rommelfanger has been an editor for several publications, including Nature Neuroscience, The Lancet Psychiatry, and the Journal of Neural Engineering.[2]

References

[edit]
  1. ^ a b c "Director, Neuroethics Program | Emory University | Atlanta GA". ethics.emory.edu. Retrieved 2024-06-10.
  2. ^ a b c d e f g h i j k Rommelfanger, Karen. Curriculum Vitae (2024)
  3. ^ a b Ahlgrim, Nathan S.; Garza, Kristie; Hoffman, Carlie; Rommelfanger, Karen S. (2019). "Prodromes and Preclinical Detection of Brain Diseases: Surveying the Ethical Landscape of Predicting Brain Health". eNeuro. 6 (4): ENEURO.0439–18.2019. doi:10.1523/ENEURO.0439-18.2019. ISSN 2373-2822. PMC 6658915. PMID 31221862.
  4. ^ a b Purcell, Ryan H.; Rommelfanger, Karen S. (2015-04-22). "Internet-based brain training games, citizen scientists, and big data: ethical issues in unprecedented virtual territories". Neuron. 86 (2): 356–359. doi:10.1016/j.neuron.2015.03.044. ISSN 1097-4199. PMID 25905809.
  5. ^ a b Rommelfanger, Karen S.; Factor, Stewart A.; LaRoche, Suzette; Rosen, Phyllis; Young, Raymond; Rapaport, Mark H. (2017). "Disentangling Stigma from Functional Neurological Disorders: Conference Report and Roadmap for the Future". Frontiers in Neurology. 8: 106. doi:10.3389/fneur.2017.00106. ISSN 1664-2295. PMC 5372777. PMID 28424653.
  6. ^ a b Rommelfanger, Karen S. (June 2013). "Opinion: A role for placebo therapy in psychogenic movement disorders". Nature Reviews. Neurology. 9 (6): 351–356. doi:10.1038/nrneurol.2013.65. ISSN 1759-4766. PMID 23628738.
  7. ^ a b Rommelfanger, Karen S.; Jeong, Sung-Jin; Montojo, Caroline; Zirlinger, Mariela (2019-02-06). "Neuroethics: Think Global". Neuron. 101 (3): 363–364. doi:10.1016/j.neuron.2019.01.041. ISSN 1097-4199. PMID 30731058.
  8. ^ a b Rommelfanger, Karen S. (2020). "Reflecting on a Neuroethics Roadmap in a Global Crisis". AJOB Neuroscience. 11 (3): 131–134. doi:10.1080/21507740.2020.1786311. ISSN 2150-7759. PMID 34029494.
  9. ^ a b Global Neuroethics Summit Delegates; Rommelfanger, Karen S.; Jeong, Sung-Jin; Ema, Arisa; Fukushi, Tamami; Kasai, Kiyoto; Ramos, Khara M.; Salles, Arleen; Singh, Ilina (2018-10-10). "Neuroethics Questions to Guide Ethical Research in the International Brain Initiatives". Neuron. 100 (1): 19–36. doi:10.1016/j.neuron.2018.09.021. ISSN 1097-4199. PMID 30308169.
  10. ^ a b Taylor, Linzie; Rommelfanger, Karen S. (July 2022). "Mitigating white Western individualistic bias and creating more inclusive neuroscience". Nature Reviews. Neuroscience. 23 (7): 389–390. doi:10.1038/s41583-022-00602-8. ISSN 1471-0048. PMID 35585252.
  11. ^ a b Shen, Francis X.; Wolf, Susan M.; Lawrenz, Frances; Comeau, Donnella S.; Dzirasa, Kafui; Evans, Barbara J.; Fair, Damien; Farah, Martha J.; Han, S. Duke; Illes, Judy; Jackson, Jonathan D.; Klein, Eran; Rommelfanger, Karen S.; Rosen, Matthew S.; Torres, Efraín (2024). "Ethical, legal, and policy challenges in field-based neuroimaging research using emerging portable MRI technologies: guidance for investigators and for oversight". Journal of Law and the Biosciences. 11 (1): lsae008. doi:10.1093/jlb/lsae008. ISSN 2053-9711. PMC 11157461. PMID 38855036.
  12. ^ a b Moss, Ankita U.; Li, Zone R.; Rommelfanger, Karen S. (2021). "Assessing the Perceived Value of Neuroethics Questions and Policy to Neuro-Entrepreneurs". Frontiers in Neuroscience. 15: 702019. doi:10.3389/fnins.2021.702019. ISSN 1662-4548. PMC 8548819. PMID 34720850.
  13. ^ a b Moss, Ankita; Rommelfanger, Karen (29 March 2021). "How neuroethics can advance innovations for positive social impact". World Economic Forum.
  14. ^ a b Atkinson, Andrew; Labbé, Natalie; Nieto, Ana; Maigné, Pascal; Rapsch, Karsten; Ruggiero, Carmelina; Oyamada, Kazuhito; Lee, MyongHwa; Melo, Luis; Henggeler, Anina; Lawson, Will; Stevens, Kate; Winickoff, David; Kreiling, Laura; Rommelfanger, Karen (April 2024). "Neurotechnology Toolkit" (PDF). Organisation of Economic Co-operation and Development.
  15. ^ a b O'Sullivan, Siobhán; Chneiweiss, Hervé; Pierucci, Alessandra; Rommelfanger, Karen (November 2021). "Neurotechnologies and Human Rights Framework: Do We Need New Human Rights?". Organisation of Economic Co-operation and Development and Council of Europe.
  16. ^ a b O'Shaughnessy, Matthew R.; Johnson, Walter G.; Tournas, Lucille Nalbach; Rozell, Christopher J.; Rommelfanger, Karen S. (2023). "Neuroethics guidance documents: principles, analysis, and implementation strategies". Journal of Law and the Biosciences. 10 (2): lsad025. doi:10.1093/jlb/lsad025. ISSN 2053-9711. PMC 10602660. PMID 37901886.
  17. ^ a b "Mind the Gap: Lessons Learned from Neurorights | Science & Diplomacy". www.sciencediplomacy.org. 2022-02-28. Retrieved 2024-07-30.
  18. ^ a b "Difficult Brain Science Brings Difficult Ethical Questions". Science Friday. Retrieved 2024-07-30.
  19. ^ "ACD BRAIN Initiative Working Group 2.0 Neuroethics Subgroup". NIH Advisory Committee to the Director. Retrieved 2024-07-30.
  20. ^ "Advisory board". Neuron. Retrieved 30 July 2024.
  21. ^ "Neuroethics". BrainMind. Retrieved 2024-07-30.
  22. ^ "New Approaches to Economic Challenges". OECD. Retrieved 2024-07-30.
  23. ^ "Engaging Scientists in Shared Responsible Innovation in Neuroscience in Southeast Asia – A Workshop Series". www.nationalacademies.org. Retrieved 2024-07-30.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Draft:Karen_Rommelfanger&oldid=1245590468"